Readers in the United Kingdom will be interested to hear that the drug industry there is apparently suffering from the same terrible, crippling shortage of people to hire that afflicts us here in the US. That’s what I get from this article, anyway. The schools have failed everyone, it seems, and despite offering thousands of open positions at high wages, the UK pharma industry just isn’t able to find enough qualified applicants. They might well have to go offshore to deal with the problem, I read.
What’s that? You say that there aren’t thousands of high-paying open positions? That thousands of people have actually been laid off all over the UK in recent years from this same industry that faces a hiring squeeze? Well, then, surely we have such a problem here in the US – after all, no less an expert than John Lechleiter, CEO of Eli Lilly, has been going around talking about this for several years, in speech after speech.
What’s that? You that, adjusted for inflation, that the salaries of chemists in general have hardly moved for thirty years? And that from 2008 to 2012, inflation-adjusted wages for the entire “life scientist” job category actually fell? And that this might indicate that demand for them has not, in fact been increasing? Madness. The shortage of qualified workers must have affected your brain. By the way, they must also be facing crippling STEM shortages in Ireland, Spain, and Italy, because Roche has announced that they’re closing facilities there (and one in the US, a plant in South Carolina), eliminating 1200 jobs overall in a rework of their manufacturing processes. In this tight, tight labor market, I’m sure all the people affected will be snapped right up, though. Right?